Clinical Trials in Massachusetts

Showing 1821-1840 of 15,316 trials

Effect of Cash Benefits on Health Care Spending

NCT07381049

During the first two years of the COVID-19 pandemic, the City of Chelsea, Massachusetts held a lottery to allocate monthly cash benefits to its residents. Using data from the Chelsea Eats program, the investigators propose to study the impact of the cash benefit on health care spending.

Health Care CostsHealth Care Utilization

Harvard Medical School (HMS and HSDM)3,615 participantsStarted Jul 2020

Boston, Massachusetts, United States • Cambridge, Massachusetts, United States • Ann Arbor, Michigan, United States

Active Not RecruitingPhase 2/326 miles

A Study of AL102 in Patients With Progressing Desmoid Tumors

NCT04871282

The current study is designed to evaluate the efficacy and safety of AL102 in patients with progressive desmoid tumors.

DesmoidDesmoid Tumor

Immunome, Inc.198 participantsStarted Mar 2021

Pheonix, Arizona, United States • Duarte, California, United States • Santa Monica, California, United States +50 more locations

Effect of Cash Benefits on Health Care Spending

A Study of AL102 in Patients With Progressing Desmoid Tumors

Find Trials by Condition in Massachusetts

Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis

The DISCOVER Study

A Study of Ripretinib vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib

A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)

A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and Venetoclax

HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis

A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)

Paclitaxel + Trastuzumab + Pertuzumab as Pre-Op for Inflammatory BrCa

Efficacy and Safety of MK-8189 in Participants With an Acute Episode of Schizophrenia (MK-8189-008)

The Kidney's Response to Exercise in Heat, and the Impact of Vitamin B3 on This Response

Safety, Tolerability, Efficacy and Pharmacokinetics of Imipenem/Cilastatin/Relebactam (MK-7655A) in Pediatric Participants With Gram-negative Bacterial Infection (MK-7655A-021)

TMS for PTSD and Blood Pressure

Study of First-line Pembrolizumab (MK-3475) With Lenvatinib (MK-7902/E7080) in Urothelial Carcinoma Cisplatin-ineligible Participants Whose Tumors Express Programmed Cell Death-Ligand 1 and in Participants Ineligible for Platinum-containing Chemotherapy (MK-7902-011/E7080-G000-317/ LEAP-011)

A Study of MGC026 in Participants With Advanced Solid Tumors

International CRDS Registry

Safety, Pharmacodynamics, and Efficacy of Migalastat in Pediatric Subjects (Aged >12 Years) With Fabry Disease

Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B

Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers

Clinical Trials in Massachusetts

Effect of Cash Benefits on Health Care Spending

A Study of AL102 in Patients With Progressing Desmoid Tumors

Find Trials by Condition in Massachusetts

Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis

The DISCOVER Study

A Study of Ripretinib vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib

A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)

A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and Venetoclax

HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis

A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)

Paclitaxel + Trastuzumab + Pertuzumab as Pre-Op for Inflammatory BrCa

Efficacy and Safety of MK-8189 in Participants With an Acute Episode of Schizophrenia (MK-8189-008)

The Kidney's Response to Exercise in Heat, and the Impact of Vitamin B3 on This Response

Safety, Tolerability, Efficacy and Pharmacokinetics of Imipenem/Cilastatin/Relebactam (MK-7655A) in Pediatric Participants With Gram-negative Bacterial Infection (MK-7655A-021)

TMS for PTSD and Blood Pressure

Study of First-line Pembrolizumab (MK-3475) With Lenvatinib (MK-7902/E7080) in Urothelial Carcinoma Cisplatin-ineligible Participants Whose Tumors Express Programmed Cell Death-Ligand 1 and in Participants Ineligible for Platinum-containing Chemotherapy (MK-7902-011/E7080-G000-317/ LEAP-011)

A Study of MGC026 in Participants With Advanced Solid Tumors

International CRDS Registry

Safety, Pharmacodynamics, and Efficacy of Migalastat in Pediatric Subjects (Aged >12 Years) With Fabry Disease

Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to &lt; 18 Years of Age) With Severe or Moderately Severe Hemophilia B

Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers

Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B